Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

EDECRIN

ETHACRYNATE SODIUM

Standard Dose
EQ 50MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview EDECRIN is listed in Drugs@FDA under application 016093 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ETHACRYNATE SODIUM Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/VIAL Sponsor BAUSCH Submission history Latest submission status date: 2005-07-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview EDECRIN is listed in Drugs@FDA under application 016093 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ETHACRYNATE SODIUM Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/VIAL Sponsor BAUSCH Submission history Latest submission status date: 2005-07-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.